1. Experiences with health care and health-related quality of life of patients with hematologic malignancies in Mexico
- Author
-
Eduardo Terreros-Muñoz, Nancy Delgado-Lopez, Claudia Infante-Castañeda, Ricardo Pérez-Cuevas, Efreen Horacio Montaño-Figueroa, and Svetlana V. Doubova
- Subjects
Biopsychosocial model ,Adult ,Male ,medicine.medical_specialty ,Health-related quality of life ,Anxiety ,Health informatics ,Health administration ,Quality of life (healthcare) ,Patient-Centered Care ,Surveys and Questionnaires ,Health care ,medicine ,Humans ,Experiences with health care ,Mexico ,Depression (differential diagnoses) ,Aged ,Quality of Health Care ,business.industry ,Depression ,Health Policy ,Nursing research ,Public health ,lcsh:Public aspects of medicine ,lcsh:RA1-1270 ,Middle Aged ,humanities ,Cross-Sectional Studies ,Family medicine ,Hematologic Neoplasms ,Quality of Life ,Female ,Hematologic malignancies ,business ,Delivery of Health Care ,Research Article - Abstract
Background In Mexico, patients with hematologic malignancies (HMs) are characterized by being at high risk and advanced stages at diagnosis and by having a low cure rate; yet information on their experiences with health care and health-related quality of life (HRQL) is scarce. We aimed to evaluate experiences with health care and HRQL of patients with HMs and the association between these patient-reported measures. Methods We conducted a cross-sectional survey in two public oncology hospitals in Mexico City. The study included outpatient cancer patients aged ≥18 years with a diagnosis of leukemia, lymphoma, or multiple myeloma. We used a patient-centered quality of cancer care questionnaire to assess patient experiences with receiving 1) timely care; 2) clear information; 3) information for treatment decision-making; 4) care to address biopsychosocial needs; and 5) respectful and coordinated care. We applied the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) to measure HRQL. We performed a multiple linear regression to evaluate the association between patient-reported experiences (independent variables) and the QLQ-C30 summary score (dependent variable). Results Of the 515 participating HM patients, 46.6% had lymphoma, 34% leukemia, and 19.4% multiple myeloma; 70.9% were at advanced stages or at high risk. Additionally, 15.1% had anxiety and 12.8% had depression. Over one third (35.9%) reported receiving clear information, 28.5% timely care, 20.6% information for treatment decision-making, 23.7% care that addressed their biopsychosocial needs, and 31% respectful and coordinated care. The mean QLQ-C30 summary score was 71.9 points. Timely care, clear information, and care that addresses biopsychosocial needs were associated with higher HRQL. Conclusions Health care services for HM patients at public oncology hospitals in Mexico need improvement. Notably, providing timely care, clear information, and care that addresses patients’ biopsychosocial needs can increase the likelihood of better HRQL. Health care providers should measure and improve the experiences of HM patients with health care.
- Published
- 2020
- Full Text
- View/download PDF